PHARMAC has reached a provisional agreement with medicine supplier Teva to fund a new brand of primidone which is most commonly used to treat and prevent seizures in people with epilepsy
Pharmac has found replacements for most of the drugs affected by the generic medicines manufacturer Apotex leaving New Zealand later this year, however many of them will initially be supplied as unapproved medicine
Evidence given to the inquest into six sudden, unexpected deaths after a Pharmac anti-epilepsy drug funding switch doesn’t clearly link the two, the chief coroner has found
Medicines New Zealand chief executive Graeme Jarvis is “frustrated” with Pharmac’s $200 million-over-four-years funding boost. But Cancer Society medical director Chris Jackson says it would be “churlish” not to see the good in the increase
Evidence given to the inquest into six sudden, unexpected deaths after a Pharmac anti-epilepsy drug funding switch doesn’t clearly link the two, the chief coroner has found
Epilepsy New Zealand’s thoughts are with the families of six people after the Chief Coroner found no clear evidence of a link between their sudden deaths and a change in the brand of the drug lamotrigine
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management